Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Intuitive Surgical Shares Jump as Sales Top Estimates

Jan. 14 (Bloomberg) -- Intuitive Surgical Inc., the maker of a $1.5 million robotic-surgery device, gained after the company’s preliminary fourth-quarter revenue topped analysts’ estimates.

Intuitive shares increased 6.8 percent to $419.88 at the close in New York. Quarterly revenue was about $576 million, the Sunnyvale, California-based company said today in a statement. That beat the $549.1 million average of 18 analysts’ estimates compiled by Bloomberg.

The shares dropped 22 percent last year, amid questions about the safety of Intuitive’s da Vinci robot and the company’s marketing and training practices. While sales of the machines fell in the quarter, revenue for its instruments and accessories rose 6 percent as more of the robotic procedures were performed, the company said.

“Expectations were for a soft quarter, so the strong fourth-quarter beat appears more than adequate,” Tycho Peterson, a JPMorgan Chase & Co. analyst, said in a note to clients that cited Intuitive’s “better-than-expected system placements.”

Total fourth-quarter revenue declined about 5 percent from a year earlier, Intuitive said.

Da Vinci sales largely took a hit in the U.S., driven by a decline in gynecological procedures and a change in hospital capital spending priorities due to health care reform, known as Obamacare.

Cost Pressures

The cost pressures are likely to persist for awhile, said Chief Executive Officer Gary Guthart at the JPMorgan Chase & Co. health-care conference in San Francisco.

“The uncertainties with regard to the implementation of the Affordable Care Act, the number of new cases coming in with new insurance coverage and what the payment reforms will mean in terms of revenue have put some uncertainty particularly into the capital acquisition cycle for our customers,” Guthart said. “As we’ve seen in the last few quarters, we suspect or expect that uncertainty will persist until the ACA starts to settle out in terms of hospitals’ ability to predict their revenues.”

The company said it had higher sales outside the country, particularly in Japan.

Full fourth-quarter results are scheduled to be released on Jan. 23, Intuitive said in the statement.

To contact the reporter on this story: Alex Nussbaum in New York at anussbaum1@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.